High expression of WISP1 promotes metastasis and predicts poor prognosis in hepatocellular carcinoma
pubmed: wnt1 2021-03-02
Summary:
CONCLUSIONS: WISP1 might contribute to the development of HCC, serving as a clinical biomarker and therapeutic target for HCC patients.